J Cardiovasc Med (Hagerstown)
Anti-inflammatory effects of GLP-1 medicines independent of weight loss Several GLP-1 medicines, including semaglutide, liraglutide, and exenatide, reduce plasma levels of C-reactive protein (CRP), a surrogate of systemic inflammation, in people with obesity or T2D
Having overweight or obesity can contribute to hormonal imbalances, insulin resistance, chronic inflammation, and altered reproductive hormone signaling, all of which may impair fertility
just focus on gentle, consistent movement
1 In a drug interaction study with the semaglutide tablet, levothyroxine exposure was increased 33% (90% CI: 1.25-1.42)
Noticeable changes in the face, waist, hips, and overall body composition